These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8112043)

  • 1. Antiviral susceptibility testing of cytomegalovirus from primary culture using shell vial assay to detect the late viral antigen.
    Lipson SM; Tseng LF; Kaplan MH; Biondo FX
    Diagn Microbiol Infect Dis; 1993; 17(4):283-91. PubMed ID: 8112043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Jabs DA; Dunn JP; Enger C; Forman M; Bressler N; Charache P
    Arch Ophthalmol; 1996 Jul; 114(7):809-14. PubMed ID: 8660163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.
    Prix L; Maierl J; Jahn G; Hamprecht K
    J Clin Virol; 1998 Jul; 11(1):29-37. PubMed ID: 9784141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistance.
    Lipson SM; Soni M; Biondo FX; Shepp DH; Kaplan MH; Sun T
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):123-9. PubMed ID: 9294702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
    Dunn JP; MacCumber MW; Forman MS; Charache P; Apuzzo L; Jabs DA
    Am J Ophthalmol; 1995 May; 119(5):587-96. PubMed ID: 7733184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening with a shell vial assay for antiviral activity against cytomegalovirus.
    Telenti A; Smith TF
    Diagn Microbiol Infect Dis; 1989; 12(1):5-8. PubMed ID: 2540934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples.
    Gerna G; Sarasini A; Percivalle E; Zavattoni M; Baldanti F; Revello MG
    J Clin Microbiol; 1995 Mar; 33(3):738-41. PubMed ID: 7751388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients.
    Sarasini A; Baldanti F; Furione M; Percivalle E; Brerra R; Barbi M; Gerna G
    J Med Virol; 1995 Nov; 47(3):237-44. PubMed ID: 8551275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication.
    Nokta M; Tolpin MD; Nadler PI; Pollard RB
    Antiviral Res; 1994 May; 24(1):17-26. PubMed ID: 7944310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of leukocyte concentration in the performance of the quantitative cytomegalovirus (CMV) antigenemia assay.
    Lipson SM; Toro A; Lotlikar M; Match ME; Kaplan MH; Shepp DH; Gong J
    Clin Diagn Virol; 1997 Aug; 8(2):151-8. PubMed ID: 9316736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.
    Chou S; Marousek G; Parenti DM; Gordon SM; LaVoy AG; Ross JG; Miner RC; Drew WL
    J Infect Dis; 1998 Aug; 178(2):526-30. PubMed ID: 9697736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the cytomegalovirus antigenemia (CMV-Ag) assay for the detection of CMV in the blood of AIDS patients.
    Lipson SM; Kaplan MH; Tseng LF; Mandel FS
    Can J Microbiol; 1993 Nov; 39(11):1059-65. PubMed ID: 8306207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
    J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
    Drew WL; Miner RC; Marousek GI; Chou S
    J Clin Virol; 2006 Oct; 37(2):124-7. PubMed ID: 16962820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
    Cherrington JM; Fuller MD; Lamy PD; Miner R; Lalezari JP; Nuessle S; Drew WL
    J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of cytomegalovirus susceptibility to ganciclovir in renal and heart transplant recipients.
    de Oña Navarro M; Melón S; Méndez S; Iglesias B; Palacio A; Bernardo MJ; Rodriguez-Lambert JL; Gómez E
    Transpl Int; 2002 Nov; 15(11):570-3. PubMed ID: 12461662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.